A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis
Clinical trial NCT00210340 · WITHDRAWN
Trial details
- NCT number
- NCT00210340
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.